MEDIMMUNE, LLC
Patent Owner
Stats
- 161 US PATENTS IN FORCE
- 20 US APPLICATIONS PENDING
- Mar 20, 2018 most recent publication
Details
- 161 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 8,811 Total Citation Count
- Mar 26, 1993 Earliest Filing
- 248 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
Publication #
Title
Filing Date
Pub Date
Intl Class
2017/0204,362 CELL CULTURE METHODS AND MEDIA COMPRISING N-ACETYLCYSTEINEJun 17, 15Jul 20, 17[C12P, C12N, C07K]
2017/0183,397 MULTI-SPECIFIC ANTI-PSEUDOMONAS PSL AND PCRV BINDING MOLECULES AND USES THEREOFMay 04, 15Jun 29, 17[A61K, C07K]
2017/0121,771 INTERFERON ALPHA-INDUCED PHARMACODYNAMIC MARKERS AND USES THEREOFOct 11, 16May 04, 17[C12Q, C07K]
2017/0114,151 MULTISPECIFIC AND MULTIVALENT BINDING PROTEINS AND USES THEREOFAug 08, 16Apr 27, 17[C07K]
2016/0363,591 DIPEPTIDYL PEPTIDASE-4 (DPP4/CD26) AS A PERIPHERAL BIOMARKER OF IL-13 ACTIVATION IN ASTHMATIC LUNGJan 26, 15Dec 15, 16[A61K, G01N, C07K]
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
9913894 Antibodies against and methods for producing vaccines for respiratory syncytial virusJul 13, 15Mar 13, 18[A61K, C12N, G01N, C07K]
9896505 Humanized anti-CD19 antibodies and their use in treatment of oncology, transplantation and autoimmune diseaseOct 08, 14Feb 20, 18[A61K, C07K]
9879067 Stabilized liquid anti-RSV antibody formulationsFeb 11, 16Jan 30, 18[A61K, C12P, C12N, C07K]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2017/0088,628 Compositions and Methods for Identifying B Cell Malignancies Responsive to B Cell Depleting TherapyAbandonedDec 09, 16Mar 30, 17[C12Q, C07K]
2017/0073,397 MrkA Polypeptides, Antibodies, and Uses ThereofAbandonedAug 23, 16Mar 16, 17[A61K, C07K]
2017/0015,758 Compositions And Methods For Modulating And Redirecting Immune ResponsesAbandonedJan 21, 15Jan 19, 17[C07K]
2016/0222,099 Methods Of Treatment With Angiopoietin-2 AntibodiesAbandonedJan 29, 16Aug 04, 16[C07K]
2016/0051,660 METHODS OF PRODUCING INFLUENZA VACCINE COMPOSITIONSAbandonedMar 04, 15Feb 25, 16[A61K, C12N]
2016/0039,883 PALIVIZUMAB EPITOPE-BASED VIRUS-LIKE PARTICLESAbandonedMar 14, 14Feb 11, 16[A61K, C12N, G01N, C07K]
2016/0039,906 METHODS AND COMPOSITIONS FOR THE INHIBITION OF TRANSPLANT REJECTIONAbandonedApr 06, 15Feb 11, 16[A61K, C07K]
2016/0038,583 INFLUENZA HEMAGGLUTININ VARIANTS AND USES THEREFORAbandonedOct 01, 14Feb 11, 16[A61K, C12N, C07K]
2015/0361,128 METHODS OF USING ION EXCHANGE CHROMATOGRAPHY TO CONTROL LEVELS OF HIGH MANNOSE GLYCOFORMSAbandonedDec 18, 13Dec 17, 15[C07K]
2015/0344,557 Liquid Antibody Formulation With Improved Aggregation PropertiesAbandonedDec 18, 13Dec 03, 15[C07K]
2015/0284,447 METHOD OF ISOLATING SYNAGIS(R) IN THE ABSENCE OF BENZONASEAbandonedNov 05, 13Oct 08, 15[C07K]
2015/0284,450 COMBINATION THERAPIES USING ANTI-PSEUDOMONAS PSL AND PCRV BINDING MOLECULESAbandonedNov 06, 13Oct 08, 15[A61K, C07K]
2015/0252,431 COMPOSITIONS AND METHODS FOR IDENTIFYING B CELL MALIGNANCIES RESPONSIVE TO B CELL DEPLETING THERAPYAbandonedMar 04, 15Sep 10, 15[C12Q, C07K]
2015/0190,479 DELIVERY OF CHOLESTERYL ESTER TO STEROIDOGENIC TISSUESAbandonedSep 05, 14Jul 09, 15[A61K]
2015/0168,375 CANCER STEM CELLS AND METHODS OF USING THE SAMEAbandonedMar 12, 13Jun 18, 15[G01N, A01K]
Top Inventors for This Owner
Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.